Leave Your Message
2181t

HOʻOLAUNA NO KA HŌʻAILONA

ʻO Alpha Lifetech Inc. Hāʻawi ʻia ma mua o 700 mau antibodies biosimilar e kūʻē i nā pahuhopu like ʻole. Uhi kā mākou papa inoa huahana iā Adalimumab Biosimilar, Bevacizumab Biosimilar, Dupilumab Biosimilar, Eptinezumab Biosimilar, Rituximab Biosimilar, Teprotumumab Biosimilar, etc. Ma muli o kā mākou hui R&D antibody ʻoihana a me ka ʻike waiwai i ka hana ʻana i ka antibody expression, hilinaʻi mākou i ka maikaʻi o kā mākou huahana antibody biosimilar a hoʻoikaika e hoʻolalelale i kāu noiʻi. Loaʻa kā mākou mau antibodies biosimilar i nā nui like ʻole mai ka pae ug a i ka g e like me ke koi a nā mea kūʻai aku. ʻO ka manawa hana he 3-4 mau pule wale nō no kāu kauoha nui.

antibody recombinant-Alpha Lifetech

Kaʻina Hana Lawelawe Kaʻina Hana Lawelawe

Loaʻa iā mākou kahi kaʻina hana hoʻopilikino piha no ka Biosimilar Antibody e lawelawe iā ʻoe ma ke kaʻina hana holoʻokoʻa.

  • 183-lawelawe1

    E hoʻolako i ka hoʻolālā

  • 183-lawelawe2

    Ka nānā ʻana i ka pahuhopu

  • 183-lawelawe3

    Hōʻoia Papahana

  • 183-lawelawe4

    Ke holomua nei ka hoʻokolohua

  • 183-lawelawe5

    Ua pau ka hoʻokolohua

  • 183-lawelawe6

    Hoʻāʻo laʻana

  • 183-lawelawe7

    Ka hana ʻana o ka antibody biosimilar

65420be751dad22160
65420bf078ef619237 b3
65420bf15cebf60107

nā nīnau pinepinenā nīnau pinepine

E pili ana i nā huahana antibody Biosimilar

nānā hou aku
  • 1

    Pehea e noi ai no kahi ʻōlelo kūʻai no nā huahana nui?

    E hoʻoholo i ka huahana kikoʻī a i ʻole nā ​​huahana āu e makemake ai e kūʻai nui. Hiki i kēia ke komo pū me nā protein recombinant, nā antibodies, a i ʻole nā ​​​​​​mea hana olaola ʻē aʻe. E ʻoluʻolu e hoʻokaʻaʻike mai iā mākou ma info@alpha-lifetech.com

  • 2

    Pehea e hiki ai iaʻu ke loaʻa ka COA o ka reagent aʻu i loaʻa ai?

    E ʻoluʻolu e leka uila mai iā mākou ma o ka leka uila info@alpha-lifetech.com no ka ʻike kikoʻī e pili ana i ka huahana.

  • 3

    He aha nā kūlana hoʻouna no ka antibody?

    ʻO ka maʻamau, lawe ʻia nā antibodies ma 2-8 ° C (mahana hau), a pono paha e lawe ʻia kekahi mau antibodies ma luna o ka hau maloʻo (-78.5 ° C) e mālama i kahi kūlana hau.

  • 4

    He aha ka biosimilar?

    ʻO nā biosimilars kahi ʻano huahana olaola kuhikuhi e like loa me ke ʻano, ka hana, ka pharmacokinetics, a me ka pono lapaʻau me nā huahana kuhikuhi i ʻāpono ʻia e ka FDA.

  • 5

    Hana like anei nā biosimilars?

    ʻO ka hoʻolālā ʻana o nā biosimilars e like me nā huahana kuhikuhi, a pono nā huahana i ka hōʻoia nui e hōʻike i ke ʻano like ma ke kūpaʻa, ka pono, a me nā hopena lapaʻau.

  • 6

    No ke aha e koho ai i ka huahana a Alpha Lifetech?

    Ua koho ʻia nā huahana a Alpha Lifetech no ko lākou kūlana maikaʻi, hilinaʻi, a me ke kumukūʻai hoʻokūkū. Ke hele nei kā mākou mau antibodies biosimilar i nā kaʻina hana hoʻomohala a me nā hoʻāʻo piha e hōʻoia i ko lākou hoʻokō ʻana i nā koi kānāwai.

  • 7

    Pehea e hana ʻia ai nā biosimilar?

    Hoʻomaka ke kaʻina hana me ke koho ʻana a me ka hoʻomohala ʻana i nā laina cell host kūpono no ka hana ʻana i ka antibody. Ke hoʻokumu ʻia ka laina cell, hana ʻia ka fermentation nui e hana i nā antibodies recombinant.

loiloi

Mea kūʻai aku
loiloi

Ua hana maikaʻi loa kēia antibody Avelumab Biosimilar (ADT1061)-Anti-PD-L1 i kā mākou mau hoʻokolohua Western blot a me ke kahe cytometry. He mea kupaianaha ke ʻano kikoʻī a me ka ʻike, me ka liʻiliʻi o ka ʻike. Ua kōkua ia iā mākou e ʻike i ka ʻokoʻa o ka hōʻike ʻana o ka PD-L1 i nā laina cell tumor me ka pololei loa. E kauoha hou aku au!

Kauka Emily Carter

Ke Kulanui ʻo Stanford

Ua hoʻohana ʻia kēia no ka immunofluorescence a me ke kahe cytometry—hōʻailona maikaʻi loa a me ka liʻiliʻi o ke kua. He mea maikaʻi loa ke ʻano kikoʻī iā EGFR, e lilo ia i mea hana maikaʻi loa no ka noiʻi ʻana i ka maʻi kanesa. Cetuximab Biosimilar (ADT1130)– Anti-EGFR mAb.

Kauka Sarah Nguyen

ʻAhahui ʻo Max Planck

Ua hāʻawi ka antibody HER2 i ka ʻike maikaʻi i kā mākou mau hoʻāʻo ELISA, e ʻike pololei ana i nā pae cytokine. Pono kekahi hoʻonui ʻana no IHC, akā i ka manawa i hoʻopaʻa ʻia ai, ua hana maikaʻi ia. E kūʻai hou aku. (Trastuzumab Biosimilar (ADT1670)-Anti-HRE2 mAb)

Kauka Raj Patel

Ke Kulanui o Melbourne

010203

Kumuwaiwai ANTIBODY e pili ana

E nānā i nā Nūhou āpau

Leave Your Message